Delayed Release Phosphatidylcholine in Chronic-active Ulcerative Colitis

In Brief Background In 2 preceding studies, delayed release phosphatidylcholine (rPC) was found to (a) improve disease activity and (b) withdraw steroids in patients with chronic-active ulcerative colitis. Goal Objective of the study was to determine the most effective rPC dose with least adverse events. Study A randomized, dose-controlled, double-blinded study. Four groups of 10 patients each with nonsteroid-treated, chronic-active ulcerative...